Skip to main content

FDA recall, , Moderate risk

SeaSpine OsteoBallast and Ballast Bone Grafts

The products were filled with approximately 4.5 cc DBM instead of approximately 7.5 cc DBM.

What happened

IsoTis OrthoBiologics, Inc., of Irvine, California, began a recall on July 2, 2026, for OsteoBallast, 45 x 17.5 mm (SeaSpine Brand), REF: 56800095, and Ballast, 45 x 17.5 mm (IsoTis Brand), REF: 02-8000-095. These demineralized bone matrix products in resorbable mesh are indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis.

The products were filled with approximately 4.5 cc DBM instead of approximately 7.5 cc DBM, which may lead to delayed fusion, incomplete fusion, pseudarthrosis, or lack of bone ingrowth. The FDA added the recall to its Enforcement Report and classified it on July 28, 2026, with distribution in Alaska, Arkansas, California, New Jersey, Ohio, Tennessee, and Washington.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI and lot code are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. OsteoBallast, 45 x 17.5 mm (SeaSpine Brand), REF: 56800095. Ballast, 45 x 17.5 mm (IsoTis Brand), REF: 02-8000-095

    UDI-DI
    • 56800095
    • 10889981149352
    • 10889981149314
    Lot code
    • 181559
    • 181550
    • 02-8000-095

Recall details

Company began the recall
Sold in

US Nationwide distribution in the states of Alaska, New Jersey, Tennessee, Arkansas, California, Washington, Ohio.

Company
IsoTis OrthoBiologics, Inc.Irvine, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99332
Recall number
Z-2820-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)